Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now?
GSK plc (NYSE:GSK) is one of the best affordable healthcare stocks to buy now.
Glaxosmithkline Plc (GSK)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 32,227,615 | $1,390,943,886 | +3% | 0.5% |
| 2. | Holocene Advisors Brandon Haley | 7,100,420 | $306,454,127 | +27% | 0.7% |
| 3. | Eversept Partners Kamran Moghtaderi | 2,120,446 | $91,518,449 | -6% | 6.31% |
| 4. | Renaissance Technologies Jim Simons | 1,987,953 | $85,800,051 | -12% | 0.11% |
| 5. | Bridgewater Associates Ray Dalio | 1,401,755 | $60,499,746 | +5% | 0.24% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,023 | $589,608 | 0.15% |
News See All
10 Best Affordable Healthcare Stocks to Buy Now
According to him, this has been a year where certain areas of healthcare, particularly those related to health spend or real significant turnarounds in business, have performed pretty well, allowing certain...
HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target
On December 10, HSBC analyst Rajesh Kumar raised the firm’s price target on GSK plc (NYSE:GSK) to 1,500 GBp from 1,200 GBp and kept a Reduce rating on the shares.
15 Global Dividend Stocks to Diversify Your Portfolio
Dividend stocks are back in focus, and not just in the US, but investors around the world are leaning into income again, and the data shows why.
GSK (GSK) Scores Win in the Form of Lung Cancer Drug's Orphan Drug Designation
GSK plc (NYSE:GSK) is one of the largest pharmaceutical companies in the world.
13 Best ADR Stocks to Invest In
ADRs, or American Depository Receipts, are the US-listed securities of foreign firms that allow investors in America to buy and trade the shares within America.
J.P. Morgan Maintains a Sell Rating on GSK plc (GSK)
In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the initiation of litigation against AnaptysBio, Inc.
11 Best Pharma Stocks to Invest In
CNBC reported on December 1 that the UK and US governments reached a deal on drug pricing.
JPMorgan Lowers GSK Price Target, Maintains Underweight Rating
On October 31, JPMorgan lowered its price target on GSK plc (NYSE:GSK) to 1,440 GBp from 1,550 GBp while maintaining an Underweight rating on the stock, according to a report by The...
12 Best European Dividend Stocks to Buy Now
Dividend investing has been gaining traction among investors not only in the US but across global markets.
Hedge Fund Resource Center Billionaire Hedge Funds
